Moderna reported $1.31M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Acadia Pharmaceuticals USD 342M 34.04M Sep/2026
Agios Pharmaceuticals USD 55.38M 10.64M Sep/2026
Alnylam Pharmaceuticals USD 1.46B 170M Sep/2026
Amgen USD 10.4B 300M Sep/2026
Arrowhead Research USD 450.82M 375.59M Sep/2026
Biogen USD 2.8B 60M Sep/2026
BioMarin Pharmaceutical USD 1.03B 40M Sep/2026
Celltrion KRW 1.24T 90B Jun/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 761K 298K Jun/2026
Divis Laboratories Ltd INR 36.76B 9.18B Sep/2026
Gilead Sciences USD 8.3B 500M Sep/2026
GlaxoSmithKline GBP 8.89B 480M Sep/2026
Incyte USD 1.56B 110M Sep/2026
Ionis Pharmaceuticals USD 243M 25M Sep/2026
Kangmei Pharma CNY 1.19B 106M Jun/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Moderna USD 1.31M 98.69M Sep/2026
Organigram Holdings CAD 105.78M 45.99M Jun/2026
Pharma Mar EUR 54.2M 4.2M Sep/2026
Puma Biotechnology USD 80.54M 33.46M Sep/2024
Qiagen NV USD 487.78M 24.66M Sep/2026
Regeneron Pharmaceuticals USD 5.12B 830M Sep/2026
Sangamo BioSciences USD 356K 125K Jun/2024
Sarepta Therapeutics USD 381.4M 19.9M Sep/2026
Sartorius EUR 926.3M 14.5M Sep/2026
Sino Biopharmaceutical CNY 19.44B 5.18B Jun/2026
Tilray USD 217.51M 74.75M Dec/2025
Ultragenyx Pharmaceutical USD 173M 41M Sep/2026
United Therapeutics USD 832.5M 49.2M Sep/2026
Vertex Pharmaceuticals USD 3.44B 110M Sep/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 1.78B 50M Sep/2026